Synergy between adiponectin and interleukin-1β on the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in fibroblast-like synoviocytes

다국어 초록 (Multilingual Abstract)

To determine whether adiponectin may have synergistic effects in combination with the proinflammatory cytokine interleukin (IL)-1β regarding the production of proinflammatory mediators during arthritic joint inflammation,synovial cells from rheumatoid arthritis (RA) patients were treated with adiponectin, IL-1β, and their combination for 24 h. Culture supernatant was collected and analyzed by enzyme-linked immunosorbent assay for levels of IL-6, IL-8, prostaglandin E2 (PGE2), vascular endothelial growth factor (VEGF), and matrix metalloproteinases (MMPs).
Adiponectin-mediated intracellular signaling pathways were investigated to elucidate the molecular mechanisms underlying their synergy. The association of proinflammatory mediators with adiponectin was investigated in the synovial fluid of arthritis patients. Adiponectin functioned synergistically with IL-1β to activate IL-6, IL-8, and PGE2 expression in RA fibroblast-like synoviocytes; Levels of VEGF, MMP-1,and MMP-13 were not synergistically stimulated.
Adiponectin and IL-1β each increased the expression of both adiponectin receptor 1 and IL-1 receptor 1.
However, adiponectin and IL-1β did not synergistically support the degradation of IκB-α or the nuclear translocation of NF-κB. Synergistically increased gene expression was significantly inhibited by MG132, an NF-κB inhibitor. Supporting the in vitro results, IL-6and IL-8 levels were positively associated with adiponectin in synovial joint fluid from patients with RA, but not osteoarthritis (OA). In conclusion, adiponectin and IL-1β may synergistically stimulate the production of proinflammatory mediators through unknown signaling pathways during arthritic joint inflammation.
Adiponectin may be more important to the pathogenesis of RA than previously thought.

참고문헌 (Reference)

1 Kay J, "The role of interleukin-1 in the pathogenesis of rheumatoid arthritis" 43 (43): iii2-iii9, 2004

2 Ehling A, "The potential of adiponectin in driving arthritis" 176 : 4468-4478, 2006

3 Ronti T, "The endocrine function of adipose tissue: an update" 64 : 355-365, 2006

4 Halberg N, "The adipocyte as an endocrine cell" 37 : 753-768, 2008

5 Kim KS, "Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes" 9 : R80-, 2007

6 Matsuda M, "Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis" 277 : 37487-37491, 2002

7 Ribatti D, "Nonclassic endogenous novel [corrected] regulators of angiogenesis" 59 : 185-205, 2007

8 Matsuzawa Y, "Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances" 892 : 146-154, 1999

9 Chiu YC, "Involvement of AdipoR receptor in adiponectin-induced motility and alpha2beta1 integrin upregulation in human chondrosarcoma cells" 30 : 1651-1659, 2009

10 Symons JA, "Interleukin 1 in rheumatoid arthritis: potentiation of immune responses within the joint" 8 : 365-372, 1989

11 Senolt L, "Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis" 35 : 247-252, 2006

12 Dayer JM, "Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells" 77 : 645-648, 1986

13 Gonzalez-Gay MA, "High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis" 26 : 596-603, 2008

14 Bartok B, "Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis" 233 : 233-255, 2010

15 Choi HM, "Differential effect of IL-1beta and TNFalpha on the production of IL-6, IL-8 and PGE2 in fibroblast-like synoviocytes and THP-1 macrophages" 30 : 1025-1033, 2010

16 Neumeier M, "Different effects of adiponectin isoforms in human monocytic cells" 79 : 803-808, 2006

17 Maeda N, "Dietinduced insulin resistance in mice lacking adiponectin/ACRP30" 8 : 731-737, 2002

18 Kahle P, "Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue" 51 : 731-734, 1992

19 Otero M, "Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis" 65 : 1198-1201, 2006

20 Bang JS, "Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models" 11 : R49-, 2009

21 Henry BA, "Adipose tissue hormones and the regulation of food intake" 20 : 842-849, 2008

22 Frommer KW, "Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis" 62 : 2886-2899, 2010

23 Kusunoki N, "Adiponectin stimulates prostaglandin E(2) production in rheumatoid arthritis synovial fibroblasts" 62 : 1641-1649, 2010

24 Kitahara K, "Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts" 378 : 218-223, 2009

25 Lee SW, "Adiponectin mitigates the severity of arthritis in mice with collageninduced arthritis" 37 : 260-268, 2008

26 Choi HM, "Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators" 11 : R161-, 2009

27 Wulster-Radcliffe MC, "Adiponectin differentially regulates cytokines in porcine macrophages" 316 : 924-929, 2004

28 Giannessi D, "Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk" 56 : 459-467, 2007

29 Brochu-Gaudreau K, "Adiponectin action from head to toe" 37 : 11-32, 2010

30 Schaffler A, "Adipocytokines in synovial fluid" 290 : 1709-1710, 2003